戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  the primary pathophysiological mechanism in hypokalemic periodic paralysis.
2 utations confer susceptibility to thyrotoxic hypokalemic periodic paralysis.
3 ta may help explain the mechanism underlying hypokalemic periodic paralysis and the patient's worseni
4 m channel (CaV1.1) have been associated with hypokalemic periodic paralysis, but how the pathogenesis
5 ystem in patients with genetically confirmed hypokalemic periodic paralysis (Cav1.1-R1239H mutation,
6 cks resemble those of patients with familial hypokalemic periodic paralysis (hypoKPP) and resolve wit
7                                              Hypokalemic periodic paralysis (hypoKPP) is characterize
8 sover trials, one involving 42 subjects with hypokalemic periodic paralysis (HypoPP) and the other in
9                                              Hypokalemic periodic paralysis (HypoPP) is a familial sk
10                                              Hypokalemic periodic paralysis (HypoPP) is an ion channe
11              Mutations in this channel cause hypokalemic periodic paralysis (HypoPP), a human autosom
12 result in a leak current through the VSD and hypokalemic periodic paralysis (HypoPP), but these have
13 nother disorder of sarcolemmal excitability, hypokalemic periodic paralysis (HypoPP), which is usuall
14 ith alterations in channel subunits, such as hypokalemic periodic paralysis in humans and the weaver
15            A novel mutation in a family with hypokalemic periodic paralysis is described.
16                               In the case of hypokalemic periodic paralysis, mutations of one of the
17 d in several human genetic diseases, such as hypokalemic periodic paralysis, myotonia, and long-QT an
18 ess in other variants of periodic paralysis (hypokalemic periodic paralysis or hyperkalemic periodic
19 ge-gated calcium channel of skeletal muscle (hypokalemic periodic paralysis), the neuronal P/Q-type v
20                                   Thyrotoxic hypokalemic periodic paralysis (TPP) is characterized by
21 897S) or CaV1.1-R2 (R900S, R1239H) linked to hypokalemic periodic paralysis type 1 and of CaV1.3-R3 (
22      Two patients with genetically confirmed hypokalemic periodic paralysis underwent calf muscle ima
23                             In patients with hypokalemic periodic paralysis versus healthy volunteers